Skip to content
DefDex

Federal award

KRS GLOBAL BIOTECHNOLOGY, INC.

W81K0015P0955

Contract

Obligated and Ceiling

Obligated (net)
$20,917.75
Ceiling (potential value, not spending)
$164,199.15
Current value
$20,917.75
Gross positive obligations
$143,281.40

Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.

Award Details

Recipient
KRS GLOBAL BIOTECHNOLOGY, INC. · JWNFEU276LP8
Owner company
Not a reviewed companyNo reviewed company owns this recipient.
Reported parent
KRS GLOBAL BIOTECHNOLOGY INC. · FBQSJNMKT7M7
Awarding agency
Department of War · sub-agency 2100 · office W81K00
Funding agency
Department of War · sub-agency 2100
Product or service (PSC)
6505 · DRUGS AND BIOLOGICALS
Industry (NAICS)
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
PIID
W81K0015P0955
Award type code
B
Actions
4 · Sep 22, 2015 to Apr 6, 2020
Why it is listed
gross positive obligations of $100k or more (contracts)

Open this award on USAspending →

Action History4

Award actions
DateFYModAction typeObligationCompany in company totals
Apr 6, 2020FY2020P00003K−$122,363.65
—
Feb 29, 2016FY2016P00002F$0.00
—
Oct 9, 2015FY2016P00001C$143,281.40
—
Sep 22, 2015FY20150—$0.00
—

Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.